RxDoctor Payments Data

Kelly Hoock

Family · Rio Rancho, NMNPI 1013660778

Payments from drug & device makers

$1,996in general payments, 2019–2025

Across 97 payments — averaging $20.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$456
  • AbbVie$324
  • Otsuka America Pharmaceutical, Inc.$267
  • Novo Nordisk$130
  • Inspire Medical Systems, Inc.$88
  • Exact Sciences$84
  • plus $648 from 18 others

What the payments were for

  • Food & beverage$1,996100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,996 in reported general payments places this provider in the 85th percentile of 1,080 family providers in New Mexico.

See all family providers in New Mexico

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban14$18,828
BelsomraSuvorexant11$5,561
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$1,889
Np ThyroidThyroid,pork11$823
Albuterol Sulfate HfaAlbuterol Sulfate13$655
Levothyroxine Sodium76$614
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst30$477
Gabapentin30$472
Lisinopril48$452
Omeprazole29$443
Losartan Potassium34$427
Tamsulosin Hcl31$414
Bupropion Hcl SrBupropion Hcl19$409
Rosuvastatin Calcium28$393
Atorvastatin Calcium45$350

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$21$18,82814 claims
MerckBelsomra$30$5,56111 claims
Teva Pharmaceuticals USA, Inc.Acyclovir$36$7312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,080 family providers in New Mexico.

Other family in Rio Rancho

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →